Sol Enterprise Value Over E B I T D A from 2010 to 2024

SLGL Stock  USD 1.65  0.67  68.37%   
Sol Gel Enterprise Value Over EBITDA yearly trend continues to be quite stable with very little volatility. The value of Enterprise Value Over EBITDA is projected to decrease to -0.88. From the period between 2010 and 2024, Sol Gel, Enterprise Value Over EBITDA regression line of its data series had standard deviation of  13.04 and standard deviation of  13.04. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(0.84)
Current Value
(0.88)
Quarterly Volatility
13.04165411
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sol Gel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sol Gel's main balance sheet or income statement drivers, such as Interest Expense of 1.6 M, Selling General Administrative of 6.8 M or Total Revenue of 1.5 M, as well as many indicators such as Price To Sales Ratio of 18.38, Dividend Yield of 0.0 or PTB Ratio of 0.82. Sol financial statements analysis is a perfect complement when working with Sol Gel Valuation or Volatility modules.
  
Check out the analysis of Sol Gel Correlation against competitors.

Latest Sol Gel's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Sol Gel Technologies over the last few years. It is Sol Gel's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sol Gel's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Sol Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(4.80)
Geometric Mean6.93
Coefficient Of Variation(271.51)
Mean Deviation7.20
Median(8.58)
Standard Deviation13.04
Sample Variance170.08
Range57.937
R-Value0.40
Mean Square Error153.91
R-Squared0.16
Significance0.14
Slope1.17
Total Sum of Squares2,381

Sol Enterprise Value Over E B I T D A History

2024 -0.88
2023 -0.84
2022 -5.98
2021 39.59
2020 -7.37
2019 -13.07
2018 -3.12

About Sol Gel Financial Statements

Sol Gel investors utilize fundamental indicators, such as Enterprise Value Over E B I T D A, to predict how Sol Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(0.84)(0.88)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Sol Gel Technologies is a strong investment it is important to analyze Sol Gel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sol Gel's future performance. For an informed investment choice regarding Sol Stock, refer to the following important reports:
Check out the analysis of Sol Gel Correlation against competitors.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sol Gel. If investors know Sol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sol Gel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.34)
Revenue Per Share
0.235
Quarterly Revenue Growth
8.146
Return On Assets
(0.22)
Return On Equity
(0.36)
The market value of Sol Gel Technologies is measured differently than its book value, which is the value of Sol that is recorded on the company's balance sheet. Investors also form their own opinion of Sol Gel's value that differs from its market value or its book value, called intrinsic value, which is Sol Gel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sol Gel's market value can be influenced by many factors that don't directly affect Sol Gel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sol Gel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sol Gel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sol Gel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.